FDA Advisory Committee Raises Concerns About Eli Lilly’s Alzheimer’s Drug Donanemab

June 8, 2024

AbbVie to Shell Out $8.7B to Purchase Cerevel

December 22, 2023

Lilly plans to construct a $2.5 billion manufacturing facility in Germany

November 21, 2023

Must Read

Top 10 Metrics Pharma Leaders Should Track During Digital Transformation

July 20, 2026

Sarclisa Escena Wins FDA Approval for Subcutaneous Use in Multiple Myeloma

July 20, 2026

Bausch + Lomb Ends BL1107 Glaucoma Program After Phase 2 Trial Misses Main Goal

July 20, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

ARPA-H Awards Up to $160 Million for Personalized Genetic Medicine Development

Biogen’s Phase 2 Diranersen Data Shows Reduced Cognitive Decline in Alzheimer’s Disease

ARPA-H Awards Up to $160 Million for Personalized Genetic Medicine Development

Early research shows that Lilly’s Verve strategy is successful in lowering cholesterol

Bausch + Lomb Ends BL1107 Glaucoma Program After Phase 2 Trial Misses Main Goal

Ionis and AstraZeneca falter as the ATTR-CM medication fails Phase 3

Axiom Reports Phase 1 Results for Stem Cell Therapy in Newborn Brain Injuries

Sac-TMT and Keytruda Improve Progression-Free Survival in PD-L1-Negative NSCLC

GSK views the Hansoh-partnered ADCs’ phase 3 victory in China as confirming its “priority asset.”

Vogenx Files for a Nasdaq Capital Market IPO to Fund Metabolic Drug

AstraZeneca travels to China once more and purchases Dizal’s lung cancer medication for up to $1.5 billion

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

Top 10 Metrics Pharma Leaders Should Track During Digital Transformation

The Return of M&A as a Growth Strategy in Biopharma

Top 10 Reasons Pharma Companies Are Building Internal AI Governance Teams

Why Traditional Pharma Marketing Models Are Being Rewritten

Tag: CNS Disorders

Vistagen Misses Second Phase 3 Social Anxiety Trial but Sees Potential Path Forward

Editor Picks

FDA Advisory Committee Raises Concerns About Eli Lilly’s Alzheimer’s Drug Donanemab

AbbVie to Shell Out $8.7B to Purchase Cerevel

Lilly plans to construct a $2.5 billion manufacturing facility in Germany

Must Read

Top 10 Metrics Pharma Leaders Should Track During Digital Transformation

Sarclisa Escena Wins FDA Approval for Subcutaneous Use in Multiple Myeloma

Bausch + Lomb Ends BL1107 Glaucoma Program After Phase 2 Trial Misses Main Goal

Hot Topics

About Us

Follow Us